177 related articles for article (PubMed ID: 35032039)
1. Deep learning-based AI model for signet-ring cell carcinoma diagnosis and chemotherapy response prediction in gastric cancer.
Li C; Qin Y; Zhang WH; Jiang H; Song B; Bashir MR; Xu H; Duan T; Fang M; Zhong L; Meng L; Dong D; Hu Z; Tian J; Hu JK
Med Phys; 2022 Mar; 49(3):1535-1546. PubMed ID: 35032039
[TBL] [Abstract][Full Text] [Related]
2. Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population-based study.
Shi T; Song X; Liu Q; Yang Y; Yu L; Liu B; Wei J
Cancer Med; 2019 Oct; 8(13):6010-6020. PubMed ID: 31448584
[TBL] [Abstract][Full Text] [Related]
3. CT-based radiomics nomograms for preoperative prediction of diffuse-type and signet ring cell gastric cancer: a multicenter development and validation cohort.
Chen T; Wu J; Cui C; He Q; Li X; Liang W; Liu X; Liu T; Zhou X; Zhang X; Lei X; Xiong W; Yu J; Li G
J Transl Med; 2022 Jan; 20(1):38. PubMed ID: 35073917
[TBL] [Abstract][Full Text] [Related]
4. Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis-a cohort study of 123 patients from a non-endemic country.
Zaafouri H; Jouini R; Khedhiri N; Khanchel F; Cherif M; Mesbahi M; Daghmouri A; Mahmoudi W; Akremi S; Sabbah M; Benzarti Y; Hadded D; Gargouri D; Bader MB; Maamer AB
World J Surg Oncol; 2022 Jul; 20(1):238. PubMed ID: 35858903
[TBL] [Abstract][Full Text] [Related]
5. Survival impact of gastrectomy and chemotherapy on gastric signet ring-cell carcinoma with different metastatic lesions: A population-based study.
Ji J; Zhang X; Yuan S; Liu H; Yang L
Asian J Surg; 2024 Apr; 47(4):1769-1775. PubMed ID: 38302357
[TBL] [Abstract][Full Text] [Related]
6. The percentages of signet-ring cells (SRCs) affects the prognosis after radical gastrectomy for advanced gastric cancer.
Ma Y; Wang Y; Hu C; Zi M; Chen J; Cao M; Yuan L; Yang L; Du Y
Langenbecks Arch Surg; 2023 Sep; 408(1):376. PubMed ID: 37743407
[TBL] [Abstract][Full Text] [Related]
7. Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study.
Jiang Y; Zhang Z; Yuan Q; Wang W; Wang H; Li T; Huang W; Xie J; Chen C; Sun Z; Yu J; Xu Y; Poultsides GA; Xing L; Zhou Z; Li G; Li R
Lancet Digit Health; 2022 May; 4(5):e340-e350. PubMed ID: 35461691
[TBL] [Abstract][Full Text] [Related]
8. Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor.
Hugen N; Verhoeven RH; Lemmens VE; van Aart CJ; Elferink MA; Radema SA; Nagtegaal ID; de Wilt JH
Int J Cancer; 2015 Jan; 136(2):333-9. PubMed ID: 24841868
[TBL] [Abstract][Full Text] [Related]
9. Deep Learning Models for Gastric Signet Ring Cell Carcinoma Classification in Whole Slide Images.
Kanavati F; Ichihara S; Rambeau M; Iizuka O; Arihiro K; Tsuneki M
Technol Cancer Res Treat; 2021; 20():15330338211027901. PubMed ID: 34191660
[TBL] [Abstract][Full Text] [Related]
10. Comparison of clinicopathological and prognostic characteristics in patients with mucinous carcinoma and signet ring cell carcinoma of the stomach.
Bozkaya Y; Erdem GU; Ozdemir NY; Demirci NS; Hocazade C; Yazıcı O; Zengin N
Curr Med Res Opin; 2017 Jan; 33(1):109-116. PubMed ID: 27646639
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study.
Pernot S; Dubreuil O; Aparicio T; Le Malicot K; Tougeron D; Lepère C; Lecaille C; Marthey L; Palle J; Bachet JB; Zaanan A; Taieb J
Br J Cancer; 2018 Aug; 119(4):424-428. PubMed ID: 29872148
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of docetaxel- and oxaliplatin-based adjuvant chemotherapy in postgastrectomy gastric cancer patients reveals obvious survival benefits in docetaxel-treated mixed signet ring cell carcinoma patients.
Chen L; Shi Y; Yuan J; Wu Q; Han Y; Qin R; Jia B; Wei B; Wei L; Dai G; Jiao S
Med Oncol; 2014 Sep; 31(9):159. PubMed ID: 25119501
[TBL] [Abstract][Full Text] [Related]
13. Signet ring cell carcinoma of the gastrointestinal tract: National trends on treatment effects and prognostic outcomes.
Franko J; Le VH; Tee MC; Lin M; Sedinkin J; Raman S; Frankova D
Cancer Treat Res Commun; 2021; 29():100475. PubMed ID: 34655861
[TBL] [Abstract][Full Text] [Related]
14. Identification of gastric signet ring cell carcinoma based on endoscopic images using few-shot learning.
Yin M; Zhang R; Lin J; Zhu S; Liu L; Liu X; Lu J; Xu C; Zhu J
Dig Liver Dis; 2023 Dec; 55(12):1725-1734. PubMed ID: 37455154
[TBL] [Abstract][Full Text] [Related]
15. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge.
Pernot S; Voron T; Perkins G; Lagorce-Pages C; Berger A; Taieb J
World J Gastroenterol; 2015 Oct; 21(40):11428-38. PubMed ID: 26523107
[TBL] [Abstract][Full Text] [Related]
16. Intracellular MUC20 variant 2 maintains mitochondrial calcium homeostasis and enhances drug resistance in gastric cancer.
Fu L; Yonemura A; Yasuda-Yoshihara N; Umemoto T; Zhang J; Yasuda T; Uchihara T; Akiyama T; Kitamura F; Yamashita K; Okamoto Y; Bu L; Wei F; Hu X; Liu Y; Ajani JA; Tan P; Baba H; Ishimoto T
Gastric Cancer; 2022 May; 25(3):542-557. PubMed ID: 35166958
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy is associated with increased survival from colorectal signet ring cell carcinoma with distant metastasis: A Surveillance, Epidemiology, and End Results database analysis.
Shi T; Huang M; Han D; Tang X; Chen Y; Li Z; Liu C; Xiang D; Wang T; Chen Y; Wang R; Lei Z; Chu X
Cancer Med; 2019 Apr; 8(4):1930-1940. PubMed ID: 30864303
[TBL] [Abstract][Full Text] [Related]
18. Microangiopathic Hemolytic Anemia Is a Late and Fatal Complication of Gastric Signet Ring Cell Carcinoma: A Systematic Review and Case-Control Study.
Lam R; Tarangelo N; Wang R; Horibe M; Grimshaw AA; Jain D; Haffar S; Bazerbachi F; Kunz PL; Li DK
Oncologist; 2022 Sep; 27(9):751-759. PubMed ID: 35589098
[TBL] [Abstract][Full Text] [Related]
19. Tumor Heterogeneity in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer Assessed by CT Texture Analysis: Association with Survival after Trastuzumab Treatment.
Yoon SH; Kim YH; Lee YJ; Park J; Kim JW; Lee HS; Kim B
PLoS One; 2016; 11(8):e0161278. PubMed ID: 27517841
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic and clinical characteristic analysis of primary signet ring cell carcinoma of urinary bladder identified by a novel OR2L5 mutation.
Alradhi M; Wen S; Safi M; Al-Danakh A; Wang H; Shopit A; Sun M; Fan B; Li X
Cancer Med; 2023 Feb; 12(4):3931-3951. PubMed ID: 36779496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
